Enclomiphene

Research ChemicalModerate Research

Also known as: Androxal · trans-Clomiphene · Enclomiphene Citrate

A selective estrogen receptor modulator (SERM) that stimulates endogenous testosterone production while preserving fertility, used as an alternative to TRT.

Overview

Enclomiphene is the trans-isomer of clomiphene citrate, isolated from the racemic mixture that also contains zuclomiphene (the cis-isomer). While traditional clomiphene (Clomid) contains both isomers, enclomiphene is preferred because zuclomiphene has a much longer half-life and accumulates, potentially causing estrogenic side effects. Enclomiphene acts as a selective estrogen receptor modulator (SERM), blocking estrogen receptors in the hypothalamus and pituitary. By blocking estrogen's negative feedback at the hypothalamus, enclomiphene increases GnRH pulse frequency, which stimulates LH and FSH release from the pituitary. This results in increased endogenous testosterone production while maintaining — or even improving — spermatogenesis.

This makes enclomiphene an attractive option for men who want to optimize testosterone levels while preserving fertility, or as an alternative to TRT for men with secondary hypogonadism. It can also be used alongside TRT at low doses to maintain gonadotropin signaling.

Mechanism of Action

Selectively antagonizes estrogen receptors (ER) in the hypothalamus and anterior pituitary, blocking estradiol's negative feedback on GnRH neurons. This increases GnRH pulsatility, stimulating gonadotroph cells to release more LH and FSH. LH stimulates Leydig cells to produce testosterone; FSH stimulates Sertoli cells to support spermatogenesis.

Key Benefits

Increases endogenous testosterone production
Preserves or improves fertility (unlike TRT)
Maintains testicular size and function
Fewer side effects than racemic clomiphene
Oral administration (no injections)
Can be used as TRT alternative or adjunct

Potential Side Effects

Headache
Hot flashes
Mood changes
Visual disturbances (rare, less than with Clomid)
Potential for elevated estradiol over time

Common Stacks

This peptide is commonly combined with the following compounds for synergistic effects:

Testosterone (low-dose)HCGAnastrozoleDHEA

Known Interactions

The following interactions have been documented for Enclomiphene. Always consult a healthcare professional before combining compounds.

Use Caution (1)

Enclomiphene stimulates natural testosterone production via SERM action. Using with exogenous testosterone is counterproductive — the exogenous T suppresses the HPG axis that enclomiphene is trying to stimulate.

Synergistic (2)

HCGSynergistic

Both support endogenous testosterone production through different mechanisms. Enclomiphene (SERM) stimulates LH/FSH release while HCG directly stimulates Leydig cells.

KisspeptinSynergistic

Kisspeptin stimulates GnRH release upstream while enclomiphene blocks estrogen's negative feedback. Both promote endogenous testosterone through complementary HPG axis mechanisms.

View all compound interactions

Scientific References

Quick Reference

Typical Dose

12.5-25 mg/day

Frequency

Once daily

Route

Oral capsule/tablet

Half-Life

~10 hours

Cycle Length

Ongoing or cyclical; monitor testosterone, LH, FSH, estradiol

FDA Status

Not FDA approved (was in Phase 3 trials as Androxal); available through compounding pharmacies

Need to calculate dosing?

Use our reconstitution calculator to determine exact syringe measurements.

Open Calculator

This information is for educational purposes only. Consult a qualified healthcare professional before using any peptide. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.

Related Peptides in Pharmaceuticals